Margaret Masterson, MD

The Cancer Institute of New Jersey (CINJ) 195 Little Albany Street, Room 4563 New Brunswick, NJ 08903 masterma@umdnj.edu

Clinical Specialty: Late Effects

Degree

• BS from College of William and Mary
• Fellowship from Children's Hospital Medical Center
• Resident from Children's Hospital of Pittsburgh
• Internship from Eastern Virginia Graduate School of Medicine Children's Hospital of the King's Daughters
• MD from Eastern Virginia

Positions

• Associate Professor (09/2001 - Present)
  Department of Pediatrics
  The Cancer Institute of New Jersey

Honors

• Survivorship Education Award ( City of Hope)
  The Cancer Insitute of New Jersey (2006)
• Institute for Children with Cancer and Blood Disorders
  The Cancer Institute of New Jersey (2007)

Society

• New Jersey Commission for Cancer Research- Childhood Cancer Workgroup (2006 - Present)

Publications

• Abel M, Bona M, Zwadniak L, Sultan R, Masterson M. Cervical Spine Hemorrhage Secondary to Neonatal Autoimmune Thrombocytopenia Journal of Pediatric Hematology/ Oncology . 2003; 25:340.
• Wells RJ, Adams MT, Alonzo TA, Arceci RJ, Buckley J, Buxton AB, Dusenbery K, Gamis A, Masterson M, Vik T, Warkentin P, Whitlock JA. Mitoxantrone and Cytarabine Induction, High Dose Cytarabine and Etoposide Intensification for Pediatric Patients with Relapsed or Refractory Acute Myleoid Leukemia. Journal of Clinical Oncology . 2003; 21:2940.
• Matloub Y, Lindemulder S, Gaynon PS, Sather H, La M, Broxson E, Yanofsky R, Hutchinson R, Heerema NA, Nachman J, Blake M, Wells LM, Sorrell AD, Masterson M, Kelleher JF, Stork LC. Intrathecal triple therapy prevents central nervous system relapse but fails to improve event- free survival when compared to intrathecal methotrexate. Blood . 2006; 108:1165.

Research

• Pediatric oncology; hematology; and leukemia.